EUVIMEDEUVIMED entdecken
Open Access

Multiplexed Functional Assessments of MYH7 Variants in Human Cardiomyocytes

Clayton E Friedman iD, Shawn Fayer iD, Sriram Pendyala iD, Wei-Ming Chien, Alexander Loiben iD, Linda Tran, Leslie S Chao, Ashley McKinstry iD, Dania Ahmed, Stephen D Farris iD, April Stempien-Otero iD, Erica C Jonlin iD und 4 weitere

Circulation: Genomic and Precision Medicine · 2024-04 · 17 (2)

DOI: 10.1161/circgen.123.004377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2024-04. Verfasst von Clayton E Friedman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle (C.E.F., W.-M.C., A.L., L.T., L.S.C., A.M., …. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pathogenic autosomal-dominant missense variants in MYH7 ( myosin heavy chain 7 ), which encodes the sarcomeric protein (β-MHC [beta myosin heavy chain]) expressed in cardiac and skeletal myocytes, are a leading cause of hypertrophic cardiomyopathy and are clinically actionable. However, ≈75% of MYH7 missense variants are of unknown significance. While human-induced pluripotent stem cells (hiPSCs) can be differentiated into cardiomyocytes to enable the interrogation of MYH7 variant effect in a disease-relevant context, deep mutational scanning has not been executed using diploid hiPSC derivates due to low hiPSC gene-editing efficiency. Moreover, multiplexable phenotypes enabling deep mutational scanning of MYH7 variant hiPSC-derived cardiomyocytes are unknown. METHODS: To overcome these obstacles, we used CRISPRa On-Target Editing Retrieval enrichment to generate an hiPSC library containing 113 MYH7 codon variants suitable for deep mutational scanning. We first established that β-MHC protein loss occurs in a hypertrophic cardiomyopathy human heart with a pathogenic MYH7 variant. We then differentiated the MYH7 missense variant hiPSC library to cardiomyocytes for multiplexed assessment of β-MHC variant abundance by massively parallel sequencing and hiPSC-derived cardiomyocyte survival. RESULTS: Both the multiplexed assessment of β-MHC abundance and hiPSC-derived cardiomyocyte survival accurately segregated all known pathogenic variants from synonymous variants. Functional data were generated for 4 variants of unknown significance and 58 additional MYH7 missense variants not yet detected in patients. CONCLUSIONS: This study leveraged hiPSC differentiation into disease-relevant cardiomyocytes to enable multiplexed assessments of MYH7 missense variants for the first time. Phenotyping strategies used here enable the application of deep mutational scanning to clinically actionable genes, which should reduce the burden of variants of unknown significance on patients and clinicians.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsCardiomyopathy, HypertrophicHumansMyocytes, CardiacMyosin Heavy ChainsCell DifferentiationCardiac Myosins

Stichwörter der Autor:innen

cardiomyopathy, hypertrophicdeep mutational scanninginduced pluripotent stem cellsmyosin heavy chain 7

Substanzen

Myosin Heavy ChainsMYH7 protein, humanCardiac Myosins

Autor:innen und Institutionen

  • Institute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle (C.E.F., W.-M.C., A.L., L.T., L.S.C., A.M., D.A., E.C.J., C.E.M., K.-C.Y.).
  • Center for Cardiovascular Biology (C.E.F., W.-M.C., A.L., L.T., L.S.C., A.M., D.A., S.D.F., A.S.-O., C.E.M., K.-C.Y), University of Washington, Seattle.
  • Department of Medicine/Cardiology (C.E.F., W.-M.C., A.L., L.T., L.S.C., A.M., D.A., S.D.F., A.S.-O., C.E.M., K.-C.Y.), University of Washington, Seattle.
  • Department of Genome Sciences (S.F., S.P., L.M.S., D.M.F.), University of Washington, Seattle.
  • Cardiology/Hospital Specialty Medicine, VA Puget Sound HCS, Seattle, WA (W.-M.C., S.D.F., K.-C.Y.).
  • Department of Laboratory Medicine and Pathology (C.E.M.), University of Washington, Seattle.

ORCID-Profile: Clayton E Friedman, Shawn Fayer, Sriram Pendyala, Alexander Loiben, Ashley McKinstry, Stephen D Farris, April Stempien-Otero, Erica C Jonlin, Charles E Murry, Lea M Starita, Douglas M Fowler, Kai-Chun Yang

Förderung

  • NHGRI NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • BLRD VA
  • NIGMS NIH HHS

Zitieren

APA

Friedman, C. E., Fayer, S., Pendyala, S., Chien, W. M., Loiben, A., Tran, L., Chao, L. S., McKinstry, A., Ahmed, D., Farris, S. D., Stempien-Otero, A., Jonlin, E. C., Murry, C. E., Starita, L. M., Fowler, D. M., & Yang, K. C. (2024). Multiplexed Functional Assessments of MYH7 Variants in Human Cardiomyocytes. Circulation: Genomic and Precision Medicine, 17(2). https://doi.org/10.1161/circgen.123.004377

Vancouver

Friedman CE, Fayer S, Pendyala S, Chien WM, Loiben A, Tran L, et al. Multiplexed Functional Assessments of MYH7 Variants in Human Cardiomyocytes. Circulation: Genomic and Precision Medicine. 2024;17(2). doi:10.1161/circgen.123.004377

BibTeX
@article{Friedman2024,
  author = {Friedman, Clayton E and Fayer, Shawn and Pendyala, Sriram and Chien, Wei-Ming and Loiben, Alexander and Tran, Linda and Chao, Leslie S and McKinstry, Ashley and Ahmed, Dania and Farris, Stephen D and Stempien-Otero, April and Jonlin, Erica C and Murry, Charles E and Starita, Lea M and Fowler, Douglas M and Yang, Kai-Chun},
  title = {Multiplexed Functional Assessments of MYH7 Variants in Human Cardiomyocytes},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2024},
  volume = {17},
  number = {2},
  doi = {10.1161/circgen.123.004377}
}
Kostenlos starten →